trial

Coronary Artery Disease in Patients Suffering From Schizophrenia

NCTId NCT02885792
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 300 (estimated)
Sponsored by Aalborg Psychiatric Hospital
Primary completion 2019-09
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
300 (estimated)
Study type
Interventional
Allocation
Non Randomized
Model
Parallel
Masking
None
Start
2015-09
Primary completion
2019-09
Eligibility
ALL · 18 Years · 90 Years

Interventions & indications

Drugs
Illness historyMeasure of social conditionsMeasure of psychiatric conditionCardiovascular measurement

Sponsors

Aalborg Psychiatric HospitalLead Sponsor

Investigators

1
Svend E. Jensen, MDPrincipal Investigator

Sites

1 total
Aalborg, Denmark

Facts & assertions

4 sourced
Enrollment
300
Phase
NA
Primary Completion Date
2019-09
Status
UNKNOWN
relationships
The graph out of here
drug
Illness history
drug
Measure of social conditions
drug
Measure of psychiatric condition
drug
Cardiovascular measurement
drug
lead_sponsor
Aalborg Psychiatric Hospital
company
indication
Cardiovascular Disease
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Svend E. Jensen, MD
person